Intertek & Globizz Enter into Strategic Partnership Offering Regulatory Services for Medical Device Manufacturers in Japan & ...
Intertek, a leading Total Quality Assurance provider to
industries worldwide, and Globizz, a leading Japanese-U.S. medical
device consulting firm, have entered a partnership offering
regulatory consulting, technical services, and strategic planning
for medical device manufacturers in Japan and the United States.
The agreement between the two companies will offer customers in
both regions the expertise and resources for easier, more efficient
market access, expanding the services for both companies, their
existing customers, and others in the industry.
The United States and Japan are two of the largest medical
device markets in the world. Japanese manufacturers looking to
enter the U.S. market must be prepared to have their products meet
requirements set by the U.S. Food and Drug Administration (FDA),
Occupational Safety and Health Administration (OSHA), state
regulatory bodies, and other entities. As a testing and
certification company, Intertek experts can assist with evaluating
products to standards, but the company required a partner to better
assist with consultative services in the product development
As a bilingual consulting group, Globizz is well-versed in
requirements and prepared to assist clients as products are
developed, assessed and certified for the U.S. The partnership will
allow Intertek to expand its medical device services in Japan,
helping medical electrical equipment and devices get to the U.S.
market quickly and efficiently. Globizz will be able to tap
Intertek’s extensive technical expertise, as well as testing and
certification solutions, for its clients looking to enter the U.S.
or Japan, expanding its services and market access.
Takahiro (Harry) Haruyama, President of Globizz, said, “For an
overseas company to succeed in the medical device market in the US,
it not only requires a good product but also the know-how of the
intricacies of the medical device market and a trusted partner in
the US for fruitful outcomes. We are honored to partner with such a
well-known, world industry leader that adds to the level of trust
and know-how and to leverage the relative strengths of each party’s
services and resources to expand both parties’ business in the US
Sunny Rai, Senior Vice President at Intertek, said, “Intertek
has always been focused on providing Total Quality Assurance
solution through an extensive, knowledgeable network of experts who
offer assurance, testing, inspection and certification services to
our clients. We are pleased to partner with Globizz to bring
much-needed consulting services to the medical device industry in
both Japan and the U.S. We look forward to partnering with Globizz
on bringing innovative, in-demand products to both markets.”
Total Quality. Assured.
Intertek is a leading Total Quality Assurance provider to
industries worldwide. Our network of more than 1,000 laboratories
in more than 100 countries delivers innovative and bespoke
Assurance, Testing, Inspection and Certification solutions for our
customers’ operations and supply chains. Intertek Total Quality
Assurance expertise, delivered consistently, with precision, pace
and passion, enabling our customers to power ahead safely.
Globizz is a business consulting group, assisting both American
and Japanese businesses, offering consulting services for Japan
market expansion, strategic planning, and market research. As one
of the first Japanese-English Bilingual FDA consulting firms,
Globizz also has a division of business consulting for Japanese
companies doing business in the United States, offering assistance
in food, cosmetics, medical devices, drugs, and animal foods.
Globizz is a 2020 MedTech Outlook Top Medical Device Consulting
version on businesswire.com: https://www.businesswire.com/news/home/20210628005049/en/
Cheryl Prejsnar US PR Manager +1 630-408-5538
Milinda Meehan United States Info@globizz.net
Saaya Hirai Japan Tokyo@globizz.net
Gráfica de Acción Histórica
De Oct 2021 a Nov 2021
Gráfica de Acción Histórica
De Nov 2020 a Nov 2021